It is my pleasure to invite you to attend the Annual Meeting of Stockholders (the “Annual Meeting”) of CURE Pharmaceutical Holding Corp.
Wednesday, September 23, 2020 at 2:00 p.m. Pacific Time
1620 Beacon Place, Oxnard, CA 93033, the location of our corporate offices.
At the Annual Meeting, we are asking you to elect our director nominees and to ratify the appointment of RBSM LLP as the Company’s independent registered public accounting firm for 2020, as described in the accompanying notice. Each of these matters is important, and we urge you to vote in favor of the election of each of the director nominees and the ratification of the appointment of our independent auditor.
We are taking advantage of the Securities and Exchange Commission rule that allows us to furnish proxy materials to our stockholders over the Internet. This e-proxy process expedites the delivery of proxy materials to our stockholders, lowers our costs, and reduces the environmental impact of the Annual Meeting. Today, we are mailing to our stockholders a Notice of Internet Availability of Proxy Materials containing instructions on how to access our proxy statement and our 2019 Annual Report to Stockholders (the “Annual Report”), as well as how to vote via proxy either by telephone, over the Internet, or in person at the Annual Meeting. The Notice of Internet Availability of Proxy Materials also contains instructions on how to receive copies of the proxy materials by mail.
It is important that you vote your shares of common stock at the Annual Meeting or by submitting your proxy, regardless of the number of shares that you own. We encourage you to access the proxy materials online and cast your vote using the instructions provided, so that your shares are represented at the Annual Meeting.
We thank you for your ongoing support of CURE Pharmaceutical Holding Corp. and we look forward to the Annual Meeting.